The use of a whole inactivated PRRS virus vaccine administered in sows and impact on maternally derived immunity and timing of PRRS virus infection in piglets
Veterinary Record Open · 2022-12 · 9 (1)
DOI: 10.1002/vro2.34 ↗Kurz gefasst
Fachartikel in der Zeitschrift Veterinary Record Open, online erschienen am 05.04.2022. Verfasst von Gerard Eduard Martín-Valls und 9 weiteren Autor:innen. Beteiligte Einrichtung: Departament de Sanitat i Anatomia Animals Facultat de Veterinària Travessera dels Turons s/n Universitat Autònoma de Barcelona Barcelona Spain. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Porcine reproductive and respiratory syndrome virus (PRRSV) vaccination is usually based on administering periodically PRRS modified live virus (MLV) in sows throughout their life. Using this schedule, transfer of maternally derived antibodies to the offspring is limited. The aim of the present study was to test the concept of priming with an MLV and boosting with a commercial inactivated virus vaccine in sows to reduce PRRSV incidence and improve productivity.
Methods
On two farms, all the sows were vaccinated with a MLV vaccine at week 8 of gestation. Then two groups were designated, one group was re‐vaccinated in the third week prior to farrowing and using a commercial inactivated vaccine (the PG group). The second group was the control group (C). Assays for PRRSV infection and productive parameters were evaluated.
Results
For both farms, the incidence of PRRSV was lower at 6 weeks of age in PG than in C ( p < 0.05). At weaning the proportion of PRRSV seropositive piglets was higher for PG as well ( p < 0.05). The litters from C sows from both farms showed a higher pre‐weaning mortality (odds ratio, C vs. PG = 1.18 ± 0.09; p < 0.05).
Conclusions
Administration of the vaccine in sows before farrowing was safe and associated with reduced incidence of PRRSV in piglets up to 6 weeks of age.
Autor:innen und Institutionen
- Departament de Sanitat i Anatomia Animals Facultat de Veterinària Travessera dels Turons s/n Universitat Autònoma de Barcelona Barcelona Spain.
- Ceva Santé Animale Libourne France.
- Ceva Animal Health Ceva Phylaxia Veterinary Biologicals Co. Ltd., Budapest Hungary.
- Cooperativa d'Artesa de Segre Artesa de Segre Lleida Spain.
- C ReSA-IRTA-UAB Campus UAB Cerdanyola del Vallès Barcelona Spain.
Zitieren
APA
Martín-Valls, G. E., Mortensen, P., Clilvert, H., Li, Y., Cortey, M., Sno, M., Barna, T., Terré, M., Guerra, N., & Mateu, E. (2022). The use of a whole inactivated PRRS virus vaccine administered in sows and impact on maternally derived immunity and timing of PRRS virus infection in piglets. Veterinary Record Open, 9(1). https://doi.org/10.1002/vro2.34
Vancouver
Martín-Valls GE, Mortensen P, Clilvert H, Li Y, Cortey M, Sno M, et al. The use of a whole inactivated PRRS virus vaccine administered in sows and impact on maternally derived immunity and timing of PRRS virus infection in piglets. Veterinary Record Open. 2022;9(1). doi:10.1002/vro2.34
BibTeX
@article{MartnValls2022,
author = {Martín-Valls, Gerard Eduard and Mortensen, Preben and Clilvert, Hepzibar and Li, Yanli and Cortey, Martí and Sno, Melanie and Barna, Timea and Terré, Marisa and Guerra, Nicolas and Mateu, Enric},
title = {The use of a whole inactivated PRRS virus vaccine administered in sows and impact on maternally derived immunity and timing of PRRS virus infection in piglets},
journal = {Veterinary Record Open},
year = {2022},
volume = {9},
number = {1},
doi = {10.1002/vro2.34}
}
EUVIMED